Antipodes discloses 4.8% Brookdale (NYSE: BKD) ownership
Rhea-AI Filing Summary
Antipodes Partners Ltd, an Australian investment adviser, reported beneficial ownership of Brookdale Senior Living Inc. common stock. It holds 11,428,834 shares, representing 4.8% of the outstanding common stock as of the event date of 12/31/2025.
Antipodes has sole power to vote and dispose of all these shares, with no shared voting or dispositive power. The position is certified as being acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Brookdale. The amended Schedule 13G is signed by Managing Director Andrew Findlay.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake in Brookdale Senior Living Inc. (BKD) does Antipodes Partners report?
Antipodes Partners Ltd reports beneficial ownership of 11,428,834 shares of Brookdale Senior Living Inc. common stock, representing 4.8% of the class as of 12/31/2025.
What type of investor is Antipodes Partners in relation to Brookdale (BKD)?
Antipodes Partners Ltd is classified as an investment adviser (IA) and files as a reporting person holding Brookdale Senior Living Inc. common stock.
Is Antipodes Partners seeking to influence control of Brookdale Senior Living Inc.?
No. Antipodes certifies the shares were acquired and are held in the ordinary course of business and not for the purpose or effect of changing or influencing control of Brookdale.
Why is this disclosure for Brookdale (BKD) labeled as Amendment No. 1 to Schedule 13G?
The document is marked as Amendment No. 1 to Schedule 13G, indicating an update to a prior beneficial ownership report for Brookdale by Antipodes Partners Ltd.
Who signed the Brookdale (BKD) Schedule 13G/A on behalf of Antipodes Partners?
The Schedule 13G/A was signed by Andrew Findlay, Managing Director of Antipodes Partners Ltd, dated 01/20/2026.